New Antimicrobial Drugs Discovery and Development

Antimicrobial resistance is threatening the management of infections such as pneumonia, tuberculosis, malaria, and AIDS. In the past, resistance could be handled by development of new drugs active against resistant microbes. However, the pharmaceutical industry has reduced its research efforts in infections; genomics has not delivered the anticipated novel therapeutics; new regulatory requirements have increased costs; antibiotic use in common infections—eg, bronchitis and sinusitis—is questioned; and, compared with other drugs, return on investments is lower for antimicrobials. 

  • Next Generation Biotherapy
  • Drug Design and Synthesis
  • Novel Drug Targets
  • Breaking Research of Drug Discovery

Related Conference of New Antimicrobial Drugs Discovery and Development

October 21-22, 2019

15th World Congress on Infection Prevention and Control

ZURICH | SWITZERLAND Venue: Movenpick Hotel Zürich Airport
November 25-26, 2019

2nd World Congress on Rare Diseases

Dubai, UAE
January 27-28, 2020

3rd Global Experts Meeting on Infectious Diseases

| Bangkok, Thailand
February 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany
March 11-12, 2020

8th International Conference on HIV AIDS STD & STIs

Barcelona, Spain
March 27-28, 2020

5th Annual Congress on Infectious Diseases

Barcelona, Spain
May 18-19, 2020

7th Global Congress on Rare Diseases & Orphan Drug

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
October 05-06, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
October 12-13, 2020

7th International Conference on Infectious Diseases & Antibiotics

Prague, Czech republic
September 28-29, 2020

13th Global Infections Conference

| Singapore
December 06-07, 2021

3rd World Congress on Rare Diseases

Dubai, UAE

New Antimicrobial Drugs Discovery and Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in